Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells by René Viñas & Cheryl S Watson
Viñas and Watson Environmental Health 2013, 12:26
http://www.ehjournal.net/content/12/1/26RESEARCH Open AccessMixtures of xenoestrogens disrupt
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Background: Our study examines the effects of xenoestrogen mixtures on estradiol-induced non-genomic
signaling and associated functional responses. Bisphenol-A, used to manufacture plastic consumer products, and
nonylphenol, a surfactant, are estrogenic by a variety of assays, including altering many intracellular signaling
pathways; bisphenol-S is now used as a bisphenol-A substitute. All three compounds contaminate the environment
globally. We previously showed that bisphenol-S, bisphenol-A, and nonylphenol alone rapidly activated several
kinases at very low concentrations in the GH3/B6/F10 rat pituitary cell line.
Methods: For each assay we compared the response of individual xenoestrogens at environmentally relevant
concentrations (10-15 -10-7 M), to their mixture effects on 10-9 M estradiol-induced responses. We used a medium-
throughput plate immunoassay to quantify phosphorylations of extracellular signal-regulated kinases (ERKs) and
c-Jun-N-terminal kinases (JNKs). Cell numbers were assessed by crystal violet assay to compare the proliferative
effects. Apoptosis was assessed by measuring caspase 8 and 9 activities via the release of the fluorescent product
7-amino-4-trifluoromethylcoumarin. Prolactin release was measured by radio-immunoassay after a 1 min exposure
to all individual and combinations of estrogens.
Results: Individual xenoestrogens elicited phospho-activation of ERK in a non-monotonic dose- (fM-nM) and mostly
oscillating time-dependent (2.5-60 min) manner. When multiple xenoestrogens were combined with nM estradiol,
the physiologic estrogen’s response was attenuated. Individual bisphenol compounds did not activate JNK, while
nonylphenol did; however, the combination of two or three xenoestrogens with estradiol generated an enhanced
non-monotonic JNK dose–response. Estradiol and all xenoestrogen compounds induced cell proliferation
individually, while the mixtures of these compounds with estradiol suppressed proliferation below that of the
vehicle control, suggesting a possible apoptotic response. Extrinsic caspase 8 activity was suppressed by estradiol,
elevated by bisphenol S, and unaffected by mixtures. Intrinsic caspase 9 activity was inhibited by estradiol, and by
xenoestrogen combinations (at 10-14 and 10-8 M). Mixtures of xenoestrogens impeded the estradiol-induced release
of prolactin.
Conclusions: In mixtures expected to be found in contaminated environments, xenoestrogens can have dramatic
disrupting effects on hormonal mechanisms of cell regulation and their downstream functional responses, altering
cellular responses to physiologic estrogens.* Correspondence: cswatson@utmb.edu
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Humans and wildlife do not usually experience XEs as sin-
gle compounds, and in fact, they probably are exposed to
dozens of them simultaneously, if low concentration
ranges are considered [1,2]. Newer studies demonstrating
that many of these compounds are quite active at very low
concentrations necessitate examination of this question to
determine if these multiple actions pose a greater health
hazard. We have chosen several compounds to study rela-
tively simple multiple exposure scenarios: bisphenol A
(BPA); its recently introduced alternative, bisphenol S
(BPS); and another ubiquitous environmental estrogen,
nonylphenol (NP). Our studies are well-based in our
knowledge of their performance as single compounds.
Bisphenol A (BPA) is a well-known endocrine dis-
ruptor that has been commercially used since 1957 [3]
for the production of consumer plastic goods, the inner
lining of metal food cans and drums, as well as the coa-
ting of thermal receipt paper [4,5]. Humans are typically
exposed to BPA by skin contact and consumption of con-
taminated food and water that have come in contact with
packaging containing BPA, particularly during the heating
of plastic containers [6]. A survey by the National Health
and Nutrition Examination Survey (NHANES) found
levels of BPA to range from 0.4 - 149 μg/L (1.8 - 660 nM)
in urine samples from 92.6% of U. S. residents ≥ 6 years
of age [7].
In-vivo studies have linked the presence of BPA to de-
velopmental disruptions including uterine morphological
alterations [8], disruptions in gonadotropin releasing
hormone signaling [9,10], and increases in the incidence
of ovarian cyst-adenomas when administered prenatally
to female rats [11,12]. Human epidemiological studies
have also associated BPA exposure with decreased sperm
viability and mobility [13], recurrent miscarriages [14],
as well as ovarian dysfunction and obesity [15]. Extensive
review of the literature by expert panels of the National
Institute of Health [16] and the National Toxicology
Program [17] also highlighted concern for altered pros-
tate, neurodevelopmental, and behavioral outcomes.
The FDA in mid-July 2012 banned the use of BPA in
the manufacturing of baby bottles and drinking cups
[18]. Increased global regulations such as these have in
turn resulted in the synthesis of alternative bisphenol
analogues as replacements for BPA [19]. One such ana-
logue is 4,40- dihydroxydiphenyl sulphone, also known as
BPS. Replacement of the BPA-carbon for the BPS-sulfur
atom in the central position allows the structure to have
increased stability against high temperatures and in-
creased resistance to sunlight [20], thus resulting in a less
leachable compound compared to BPA [21]. However, if
XEs are present even in very small amounts and are po-
tent, they can have effects that mimic or alter responses to
physiologic estrogens.BPS was recently detected in a variety of paper pro-
ducts, including 87% of paper currencies sampled from
21 different countries (geometric mean of 0.029 μg/g)
[22]. BPS was detected in 97% of urine samples (n = 31)
from residents of Albany, NY in appreciable amounts
[geometric mean of 0.299 ng/ml; 1.2 nM] [23]. The
structural similarity of BPS to physiologic estrogens and
to the known endocrine disruptor BPA originally raised
questions over its safety and its endocrine-disrupting po-
tential. Several in vitro studies testing the effects of BPS
via genomic mechanisms have shown BPS to mimic es-
trogenic responses [20,24-27]; however, such studies
were done at high concentrations unlikely to be leached
from BPS-containing products [21]. We very recently
demonstrated that BPS is potently estrogenic via non-
genomic signaling pathways in the GH3/B6/F10 rat pi-
tuitary cell line, including at the low-dose ranges likely
to be present in food items and human fluids [28]. This
study also demonstrated that BPS can strongly interfere
with the signaling actions of the endogenous estrogen,
estradiol (E2), at picomolar- and sub-picomolar concen-
trations, predominantly via membrane-bound estrogen
receptor-α (mERα), leading to alterations in functional
responses – cell proliferation and prolactin (PRL) re-
lease. Previous studies from our group also examined
the estrogenic actions of BPA and NP via this rapid sig-
naling pathway with similar consequences on functional
endpoints [29-32].
The aim of our present study was to determine if mix-
tures of XE compounds could cause signaling alterations
(i.e. antagonistic or additionally agonistic) on E2-induced
non-genomic signaling correlated to functional cellular
endpoints. To recreate likely real-world scenarios for ex-
posure to mixtures, we compared each compound alone
to a tertiary mixture (BPS + BPA + E2), and a quaternary
mixture (BPS + BPA +NP + E2) over wide concentration
ranges of the XEs. We examined XE mixtures in combin-
ation with a physiologic level of E2, as that is the way most
organisms will experience them. In addition, we evaluated
the effects of these mixtures on MAPK-associated down-
stream functional endpoints: cell proliferation; apopto-
sis (caspase 8 and 9 activity); and PRL secretion. Our
medium-throughput quantitative plate assays make pos-
sible within-assay comparisons between responses to dif-
ferent compounds and their mixtures at a wide range of
concentrations.
Methods
Cells and culture conditions
The GH3/B6/F10 rat prolactinoma cell line was originally
selected on the basis of its naturally high expression of
mERα [33-35]. Cells were routinely sub-cultured with
phenol red-free Dulbecco’s Modification of Eagle’s Medium
(DMEM, high glucose; Mediatech, Herdon,VA) containing
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and defined supplemented calf and fetal serum
(Thermo Fisher, Waltham, MA) at 2.5% and 1.5%,
respectively. Cells of passages 10–20 were used for
these experiments.
Quantitative ERK and JNK Phosphorylation assays
A fixed cell-based immunoassay was employed to quan-
tify phospho-activation of ERK (pERK) and JNK (pJNK),
as previously developed and described in detail [36].
Cells (104/well) were plated in 96-well plates (Corning
Incorporated, Corning, NY) and allowed to attach for
24 hrs. The cells were then cultured in DMEM con-
taining 1% charcoal-stripped (4X) serum for 48 hrs to
deprive the cells of serum hormones. Medium was then
removed and the cells exposed to individual XEs alone
or as mixtures with a physiologic level of E2 (10
-9 M;
Sigma-Aldrich, St. Louis, Mo) to assess time- (0-60 min)
and concentration-dependent (10-15-10-7 M) changes
(at 5 min). Both the short time points and range in con-
centrations chosen were based upon recently published
studies from our group [30,31,37,38]. The short time
points ensure that we are indeed observing a rapid non-
genomic activation of ERK and JNK without genomic
interferences, while the concentrations are reflective of
levels found in the environment. Test compounds were
dissolved in ethanol then diluted in DMEM containing
1% charcoal-stripped serum. Vehicle control (V) was
0.001% ethanol in DMEM. To stop mER-initiated signal-
ing, cells were fixed with a 2% paraformaldehyde/0.2%
picric acid solution (Fisher Scientific, Pittsburgh, PA)
and incubated at 4°C for 48 hrs. The cells were then
incubated with phosphate–buffered saline (PBS) con-
taining 0.2% fish gelatin and 0.1% Triton X-100
(Sigma-Aldrich) for 1 hr at room temperature (RT),
followed by overnight incubation at 4°C with primary
antibodies (Abs) against pERK or pJNK (Cell Signaling
Technology, Beverly, MA; 1:500 in PBS/0.2% fish
gelatin/0.1% TritonX-100). The cells were then washed
with PBS (3X) before biotin-conjugated Ab (Vector
Labs, Burlingame, CA) was applied and incubated
(1 hr) at RT (1:500 in PBS/0.2% fish gelatin). The
cells were again washed in PBS (3X) and incu-
bated with Vectastain ABC-AP solution (Vector Labs;
50 μL/well) for 1 hr at RT, followed by alkaline phos-
phatase substrate (pNpp solution; 50 μL/well). The
plates were incubated in the dark for 30 min at 37°C
and the signal for the product of para-nitrophenol
phosphate (pNpp) (Thermo Scientific, Rockford, IL)
breakdown to pNp was read at A405 in a model 1420
Wallac microplate reader (Perkin Elmer, Boston, MA).
The pNp signal was normalized to cell number, deter-
mined by the crystal violet (CV) assay at A590, as
described in [39].Effects on cell numbers
We have previously described this method for estimating
cell numbers in detail [40]. Briefly, sub-confluent cells
were seeded into 96-well plates that had been coated with
poly-D-lysine (5000 cells/well) and allowed to attach over-
night. Plating medium was then replaced with DMEM
containing 1% 4X charcoal-stripped serum for 48 hrs, then
treated with media containing increasing concentrations
of individual XEs (10-15-10-7 M) or mixtures of BPS +
BPA + 10-9 M E2 or BPS + BPA +NP + 10
-9 M E2. After
3 days, cells were fixed (2% paraformaldehyde/0.1% gluta-
raldehyde in PBS; 50 μl/well) and cell numbers were
assessed by CV assay to compare the proliferative effects
of XE-mixtures at different concentrations.
Determination of caspase activities
Caspase-8 and -9 activities were assessed as previously des-
cribed [40]. Sub-confluent GH3/B6/F10 cells were seeded
into 96-well plates (5 × 103/well) and allowed to attach
overnight. Treatments began the next day; cells were ex-
posed for 8 hrs to 1 nM E2, 10
-14 M and 10-8 M individual
XEs, and mixtures in DMEM-1% 4X charcoal-stripped
serum; treatment medium was suctioned off and the cells
lysed with 50 μL lysis buffer (10 mM Hepes; 2 mM EDTA;
0.1% CHAPS; pH 7.4) to which 1 mM DTT (1:2000, freshly
prepared, Sigma-Aldrich) had been added. Plates were then
stored at −70°C until assay. Staurosporine [500 nM]
(Sigma-Aldrich) dissolved in DMSO was used as a positive
control for activation of caspase-8 and -9. The released
fluorescent product 7-amino-4-trifluoromethylcoumarin
(AFC) was read using a Flexstation 3 spectrofluorometer
(Molecular Devices, Sunnyvale, CA) at 400 nm excitation,
and 505 nm emission wavelengths.
Prolactin release
These assay conditions were based on our previous
studies [32,38]. Cells (0.5–0.7× 106) were plated into poly-
D-lysine-coated 6-well plates overnight and hormone-
deprived in DMEM-1% 4X charcoal-stripped serum for
48 hrs. Cells were then pre-incubated for 30 min in
DMEM/0.1% BSA and exposed for 1 min to different con-
centrations of individual XEs alone (10-15 -10-7 M), or as
mixtures with 10-9 M E2, then centrifuged at 4°C, 350 × g
for 5 min. The supernatant was collected and stored
at −20°C until radioimmunoassay (RIA) for PRL. Cells
were then fixed with 1 ml of 2% paraformaldehyde/0.1%
glutaraldehyde in PBS, and cell numbers determined via
the CV assay. PRL RIA concentrations were determined
with a Wizard 1470 Gamma Counter (Perkin Elmer) and
normalized to CV values.
Statistical analysis
Statistical analyses were performed using Sigmaplot version
12.3 (Systat Software Inc). One-way analysis of variance
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studies to assess the statistical significance of mean values
produced by varying exposures. A Holm-Sidak comparison
against vehicle control or against E2 treatment was used to
evaluate significance. The overall α level selected for the
statistical analysis was 0.05.Results
Temporal changes in phospho-activation of MAPKs by
BPS, BPA, and NP, and their combinations, during a
60 min exposure
The time dependence of these responses was examined at
optimal response concentrations (see Figure 1). E2 pro-
duced a typical oscillating two-peak ERK response, with
the first peak within 5 min, followed by a second peak at
30 min as we have observed previously [31,35-37]. During
the same 60 min time frame XEs generated temporal pro-
files different from E2 (Figure 1A). The combination of
10-14 M XEs and 10-9 M E2 (Figure 1B) caused a deviation
from the E2−induced temporal pattern, as well a decrease
of the overall ERK response, as was also seen in the dose-
dependent studies (see below). Similar deviations due to
other XE combinations with E2 have been previously do-
cumented [30,31,37,38]. Therefore, even at this very low
concentration (10-14 M), XEs are capable of disrupting the
timing of the response to a physiologic estrogen.
Neither BPA nor BPS could maintain activation of
JNK by themselves during the 60-min time course
(Figure 2A); however, their combination with E2 (3-
compound mixture) did activate JNK with a significant
60-min response, by which time the response to E2 had
declined to control values (Figure 2B). As a 4-compoundFigure 1 Timing of ERK activation by E2, XEs, and XE/E2 mixtures. Rat
(10-14 M) and/or E2 (10
-9 M) over a 60- min time course. Responses to indiv
the pNp signal generated for each well was normalized to cell number (m
vehicle (V)-treated controls. All error bars represent S.E M. The width of the
* = p < 0.05 compared to vehicle (V); # = p < 0.05 compared to 10-9 M E2.mixture, E2 plus all XEs inactivated JNK to below vehicle
control values early in the time course, but then activated
and sustained pJNK after 30 min. Overall, these combi-
nations with XEs markedly attenuated the E2-induced
JNK response.Concentration-dependent changes in phospho-activation
of MAPKs by a short exposure to BPS, BPA, and NP, and
their combinations
We have previously determined dose–response profiles for
BPS [28], and they are described here for comparison. Short
exposures (5 min) to individual XEs (Figure 3A) caused
ERK activation in GH3/B6/F10 cells at concentrations simi-
lar to those elicited by E2 [30,31]. The lowest tested XE con-
centrations evoked a higher pERK response than did 10-9
M E2. The responses steadily decreased with increasing XE
concentrations. Responses to femtomolar concentrations of
individual XEs were statistically different (by one-way
ANOVA) from those in the nanomolar range and from the
zero concentration point, indicating a non-monotonic
dose–response [41]. The combination of XEs of increasing
concentrations with constant 10-9 M E2 (Figure 3B) reduced
ERK activity below that of either E2 or XEs alone, reaching
vehicle control levels at the highest concentrations.
Individual bisphenol compounds deactivated pJNK
below vehicle levels (Figure 4A), unlike E2 and NP that
both activated JNK. However, when E2 was administered
together with both bisphenol compounds (Figure 4B),
JNK was strongly activated, featuring a non-monotonic
dose–response curve with the lowest concentrations
evoking the largest responses; the 4-compound mixture
evoked no activation of JNK and was consistently,pituitary cells were exposed to BPS (10-14 M), BPA (10-14 M), NP
idual XEs (A) and mixtures (B) were measured by plate immunoassay;
easured by the CV assay). Values are expressed as percentage of
vehicle bar represents a S.E. of ±1.2 (n = 24 over 3 experiments).
Figure 2 Timing of JNK activation by E2, XEs, and XE/E2 mixtures. Rat pituitary cells were exposed to BPS (10
-14 M), BPA (10-14 M), NP (10-14 M)
and/or E2 (10
-9 M) over a 60- min time course. Responses to individual XEs (A) and mixtures (B) were measured by plate immunoassay; the pNp signal
generated for each well was normalized to cell number (measured by the CV assay). Values are expressed as percentage of vehicle (V)-treated controls.
All error bars represent S.E M. The width of the vehicle bar represents a S.E. of ± 1.0 (n = 24 over 3 experiments). * = p < 0.05 compared to vehicle (V);
# = p < 0.05 compared to 10-9 M E2.
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to vehicle, thus erasing the response to 1 nM E2.
XEs and mixtures affect cell proliferation
After a 3-day exposure, 10-9 M E2 and BPS had similar
effects on cell proliferation [28]. We now looked at the
dose responsiveness at this 3-day time point, demon-
strating non-monotonic stimulations (Figure 5A), as weFigure 3 ERK activation dose-response analysis by E2, XEs, and mixtu
concentrations (10-15 M – 10-7 M) of BPS, BPA, and NP, compared to a sing
concentration throughout the XE dose-response range. Individual XEs (A) a
a 5-min exposure time. All error bars represent S.E M. The widths of the ve
for both A and B, (n = 24 over 3 experiments). * = p < 0.05 compared to ve
is significantly different compared to the vehicle control.observed previously with E2 and other XEs [38,40]. NP
did not increase cell numbers significantly compared to
vehicle until it reached 10-11 M, and BPA until it reached
10-7 M. Both XE mixtures with E2 (Figure 5B) failed to
stimulate cell proliferation, but instead suppressed cell
numbers far below those seen with vehicle, again showing
these compounds’ ability to disrupt a response to a physio-
logic estrogen.res. GH3/B6/F10 rat pituitary cells were exposed to increasing
le physiological level of E2 (10
-9 M). E2 (10
-9 M) is at a constant
nd XE mixture responses (B) were measured by plate immunoassay at
hicle and E2 [10
-9 M] bars represent a S.E. of ± 1.5 and ± 1.2 respectively
hicle (V); # = p < 0.05 compared to 10-9 M E2. The E2 (10
-9 M) response
Figure 4 JNK activation dose-response analysis by E2, XEs, and mixtures. GH3/B6/F10 rat pituitary cells were exposed to increasing
concentrations (10-15 M – 10-7 M) of BPS, BPA, and NP compared to a single physiological level of E2 (10
-9 M). E2 (10
-9 M) is at a constant
concentration throughout the dose-response. Individual XEs (A) and XE mixtures (B) were measured by plate immunoassay at a 5-min exposure
time. All error bars represent S.E M. The widths of the vehicle and E2 [10
-9 M] bars represent a S.E. of ± 1.3 and ± 1.2 respectively, (n = 24 over 3
experiments). * = p < 0.05 compared to vehicle (V); # = p < 0.05 compared to 10-9 M E2. The E2 (10
-9 M) response is significantly different
compared to the vehicle control.
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Initiation of apoptosis is one of several factors that
can influence cell numbers; we therefore assayed
caspase 8 and 9 activities to determine if the extrinsic
or intrinsic apoptotic pathways were activated over an
8-hr exposure period, the optimum time that was de-
termined previously [28]. Caspase 8 was significantlyFigure 5 XEs cause cell proliferation, and XE mixtures disrupt cell pro
(10-15 M – 10-7 M) compared to increasing concentrations of E2 (10
-15
Mixtures of E2 with XEs were assessed in B. Cell number was measured
(n = 24 over 3 experiments). All error bars represent S.E M. The width o
to vehicle; in B, # = p < 0.05 compared to 10-9 M E2.activated by BPS at both concentrations used (10-
14 M and 10-8 M), while BPA, NP, and the mixture
solutions at their respective concentrations did not
result in significant activations (Figure 6A). Activa-
tions of caspase 9 were not detected with either indi-
vidual XEs or mixtures, indicating that the extrinsic
pathway (caspase 8) and not the intrinsic pathwayliferation evoked by E2. Increasing concentrations of XEs
M-10-7 M) alone (A) were assessed after a 3-day growth period.
by the CV assay and compared to vehicle (V)-treated cells
f the vehicle bar represents a S. E. of ± 1.3. * = p < 0.05 compared
Figure 6 Activation or deactivation of caspases 8 and 9 by E2, XEs, and mixtures. Over an 8-hr exposure period we measured caspase 8
(A) and 9 (B) activity evoked by two different concentrations of BPS, BPA, and NP (10-14; 10-8 M) separately and together, with each other and
with a physiological level of E2 (10
-9 M). E2 (10
-9 M) is at a constant concentration throughout. Caspase activity was measured by the release of a
fluorogenic product (AFC) expressed as the percentage of vehicle (V)-treated controls. Staurosporine (STR, 500nM) was used as a positive control
for induction of caspase activities compared to its own DMSO V control (n = 24 over 3 experiments). Error bars are means ± S.E. * = p < 0.05
compared to V.
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http://www.ehjournal.net/content/12/1/26(caspase 9) is the primary apoptotic pathway acti-
vated. However, both mixture combinations at the
highest concentrations (10-8 M) resulted in a signifi-
cant deactivation of caspase 9 activities (Figure 6B). Stau-
rosporine, the positive control for activation, was active on
both caspases, as expected. E2 by itself suppressed caspaseFigure 7 XEs cause PRL release, and XE mixtures alter these response
1-min exposure to (A) individual XEs (10-15 M – 10-7 M) and also as (B) XE m
concentration (10-9 M) throughout the dose-response range of the XEs. Th
value for cell number, and expressed as a percentage of vehicle (V)-treated
controls, the width of the bars indicate error ranges (V ±1.5; 10-9 M E2 ± 1.6). n
in B, # = p < 0.05 compared to 10-9 M E2. The E2 (10
-9 M) response is significanactivity below vehicle controls for both apoptotic path-
ways, as we had seen previously [28,40].
Mixtures of XEs disrupt E2-induced PRL release
The rapid non-genomic secretion response for PRL
caused by estrogenic exposure in GH3/B6/F10 cells hass. We measured PRL release into the culture medium by RIA after a
ixtures (10-15 M – 10-7 M) with a constant physiologic E2
e amount of PRL secreted for each well was normalized to the CV
controls. Error bars are means ± S.E. For positive (E2) and negative (V)
= 24 over 3 experiments. * = p < 0.05 compared to vehicle;
tly different compared to the vehicle control.
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tional endpoints [30-32,38,42,43]. After a 1-min expos-
ure, BPS could not increase PRL secretion as did E2
(Figure 7A [28]). At certain concentrations, BPA and NP
were able to significantly increase PRL release, even
above that caused by nM E2 (Figure 7A); the shape of
these dose–response curves are non-monotonic (as con-
firmed by determining that values at the peaks of activa-
tion were statistically different than those at other, usually
higher, concentrations). As XE mixtures with 10-9 M E2,
the 3-compound mixture inhibited E2-induced PRL
release at low concentrations (significantly at 10-11 M).
The 4-compound mixture caused more extreme inhibi-
tions, even below the vehicle level at the lower concen-
trations (Figure 7B). Though the 4-compound mixture at
10-8 M appears to have resulted in PRL release, the errors
in these mixture measurements did not allow this res-
ponse to be distinguished as statistically different from
vehicle, and the mixed signaling patterns caused by the
multiple ligands may contribute to this variability.
Discussion
Our study confirms that the novel BPA substitute, BPS,
can initiate rapid non-genomic signaling in pituitary
cells at environmentally relevant concentrations (as low
as femtomolar-picomolar), as do the more thoroughly
tested BPA and NP. In combination these compounds
altered endocrine responses differently, and more dra-
matically. Together, these compounds also interfered
with the actions of the physiologic estrogen E2 resulting
in alterations to functional endpoints. These results not
only highlight the need for stricter regulatory require-
ments for XEs, but also address the need to identify
potentially adverse interactions of new chemicals with
already existing chemicals in the environment. Such
endocrine-disrupting effects should be identified during
the initial phases of product development so that hazar-
dous new combination exposures can be prevented [44].
We previously determined that BPS, BPA, and NP had
similar high potencies, compared to E2, for initiating the
phospho-activation of ERK and JNK across a wide range
of concentrations and times [28,31,32,37,38,40,45]. Non-
monotonic dose–response curves were seen, as low
concentrations of individual XEs produced high MAPK
activation, decreasing as concentrations increased. The
occurrence of non-monotonic responses is the source of
much debate. In regards to our system, such occurren-
ces could be due to: 1) negative feedback regulation
of MAPKs as concentrations increase, thereby preven-
ting unnecessary pathway activation; 2) receptor down-
regulation or desensitization; 3) the presence of multiple
receptor subtypes that bind to the same ligand yet ini-
tiate interactions with different signaling partners, there-
by eliciting different response patterns (stimulatory orinhibitory); and/or 4) the activation of multiple pathways
from the same receptor, where signaling can be redun-
dant or divergent [41,46-49]. The more detailed mecha-
nisms responsible for these non-monotonic responses
are still largely unexplored at the cellular level.
The phospho-activation of ERK and JNK is often asso-
ciated with opposing functional endpoints. ERK signaling
promotes cell growth and differentiation by activating
pro-survival enzymes [50] and inhibiting apoptotic en-
zymes such as caspases [51-53]. Conversely, JNK signaling
is often associated with inflammation or the initiation of
cell death, and activating pro-apoptotic proteins (inclu-
ding Bax, caspase-3, Fas, cyclin D1 and under some cir-
cumstances, interleukin 1) [54-58]. Our data have shown a
correlation between the increase in cell numbers and ERK
activation by BPS, as we discussed previously [28]. How-
ever, BPA and NP were slightly more efficacious than BPS
at activating ERK, yet were unable to increase cell num-
bers as effectively, suggesting that pro-apoptotic proteins
may also be involved in regulating final cell number out-
comes. Dramatic decreases in cell numbers, in particular
with the 4-compound mixture, could be due to the attenu-
ation of the E2-induced ERK activation, as ERK activations
are usually linked to cell proliferation responses. Our
present data therefore present another example of how
the final cell number outcome is dependent on the overall
balance between ERK and JNK related activities [59,60].
Caspase activation by XE mixtures was also examined
to determine whether activation occurred via an exter-
nal stimulus (caspase 8) or through an internal stimulus
(caspase 9), and to correlate caspase activity to changes in
cell numbers. We previously reported that BPS at two
concentrations (10-14 M and 10-8 M) throughout a
4–24 hr time course resulted in activation of caspase 8,
with a delayed and probably secondary activation of
caspase 9 [28]. However, here we show that BPA, NP, and
their mixtures did not activate, and in some cases
(as when combined with 10-9 M of E2), deactivated
caspases. Deactivation of caspase activity protects cells
from death and contributes to E2’s well-known prolifera-
tive effect on the GH3 cell lines [38,40,61] and other can-
cer and normal cells. Caspases also contribute to the
inhibition of cell proliferation by XE mixtures, but cell
numbers are clearly not controlled by caspases alone. The
balance of multiple factors – including the actions of se-
veral pro-apoptotic or anti-apoptotic enzymes and other
proteins – may contribute, along with numerous other
proteins that control the cell cycle. However, it is clear
that XEs can alter such responses.
A broad range of BPA and NP concentrations induced
significant PRL secretion, with some compounds produ-
cing non-monotonic dose responses, agreeing with previ-
ous studies from our lab [32,38]. However, mixtures of
BPS with BPA, and additionally NP, disrupted E2-induced
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compared to individual XE compounds. Such inhibitory
actions could be part of a negative feedback mechanism
protecting against excess stimulation by multiple estro-
gens causing unnecessary PRL release. Because PRL regu-
lates over 300 biological functions directly and indirectly
[62], alteration of its secretion (either enhancement or
inhibition) can cause many different physiologic compli-
cations, including such medical problems as metabolic
dysfunctions, behavioral disturbances, or reproductive and
offspring-rearing failures.
We cannot know for sure if effects in cells and even
animal models represent what will happen to humans,
because humans usually will not manifest these exposure-
based adverse health effects for many years. BPS has only
been present in products and the environment for a short
time, and therefore, the epidemiology results will not be
available for some time to come. In real-world situations,
environmental and even occupational exposures are rarely
due to a single chemical, but instead involve complex
chemical mixtures. Potential health hazards from mixtures
are a challenge for regulatory agencies to evaluate, due to
the difficulty of testing a vast number of chemical interac-
tions that target various mechanisms and that can be
tissue-dependent; these evaluations also require the tes-
ting of ever-increasing numbers of chemicals. These quan-
titative approaches should also contribute to the ability of
any regulatory agency to systematically study the interac-
tions of any combinations of compounds including con-
taminants, drug-drug interactions and drug-pollutant
interactions in the drug development process [63].
Conclusions
Adverse actions from chemicals introduced to the envi-
ronment should be suspected whenever they can disrupt
the actions of a physiologic hormone like E2. In addition,
compounds acting as estrogens on their own and possibly
causing estrogenic responses in an organism at inappro-
priate life stages have been shown in many studies to be
unfavorable. As growing concern over the safety of BPA
has led to stricter regulatory actions, we are likely to see
other chemical replacements offered. The increased pres-
ence of BPS in an environment already contaminated with
BPA, NP, and a variety of other prevalent and persistent
environmental pollutants now requires increasing scrutiny
of their potential hazards as chemical mixtures, and espe-
cially those that act via ERs [31,36,64]. Our tissue-relevant
responses, such as the ones we have demonstrated with
these medium -throughput quantitative assays in pituitary
cells, offer efficient test systems that could be used to
monitor pollutant mixtures at the cellular level. In addition,
altered pituitary responses are very likely to have con-
sequences for all other endocrine tissues. However, it is
important to establish effective pre-screening of theendocrine-disruptive potential of any new chemicals whose
structures make them candidates for these endocrine-
disruptive activities in the future [44].
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